VentriPoint Diagnostics Ltd
XTSX:VPT
Balance Sheet
Balance Sheet Decomposition
VentriPoint Diagnostics Ltd
VentriPoint Diagnostics Ltd
Balance Sheet
VentriPoint Diagnostics Ltd
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
2
|
0
|
2
|
0
|
0
|
1
|
9
|
5
|
1
|
0
|
|
| Cash Equivalents |
0
|
0
|
2
|
0
|
2
|
0
|
0
|
1
|
9
|
5
|
1
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
3
|
1
|
2
|
0
|
0
|
1
|
10
|
6
|
2
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
-23%
|
3
+364%
|
1
-66%
|
2
+154%
|
1
-76%
|
0
-45%
|
1
+155%
|
10
+1 091%
|
6
-37%
|
2
-68%
|
1
-65%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
1
|
2
|
0
|
2
|
2
|
1
|
2
|
2
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
1
|
1
|
0
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
3
|
3
|
4
|
5
|
1
|
2
|
2
|
1
|
1
|
1
|
3
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
3
-11%
|
3
-11%
|
4
+30%
|
5
+14%
|
2
-66%
|
3
+80%
|
3
+13%
|
1
-62%
|
1
+18%
|
2
+19%
|
4
+115%
|
|
| Equity | |||||||||||||
| Common Stock |
16
|
25
|
28
|
31
|
36
|
29
|
29
|
31
|
42
|
43
|
43
|
44
|
|
| Retained Earnings |
23
|
33
|
33
|
39
|
44
|
35
|
38
|
40
|
44
|
49
|
53
|
58
|
|
| Additional Paid In Capital |
3
|
5
|
5
|
5
|
6
|
5
|
6
|
6
|
10
|
10
|
11
|
12
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
3
+8%
|
0
+88%
|
3
-811%
|
2
+28%
|
1
+56%
|
2
-152%
|
2
+5%
|
8
N/A
|
5
-45%
|
0
-96%
|
3
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
1
-23%
|
3
+364%
|
1
-66%
|
2
+154%
|
1
-76%
|
0
-45%
|
1
+155%
|
10
+1 091%
|
6
-37%
|
2
-68%
|
1
-65%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
144
|
186
|
27
|
32
|
52
|
60
|
69
|
90
|
156
|
157
|
157
|
162
|
|